Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540)
South Korea · Delayed Price · Currency is KRW 9,250.00
-90.00 (-0.96%)
At close: Oct 23, 2026
Ahn-Gook Pharmaceutical Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 345,078 | 306,874 | 271,116 | 233,676 | 205,389 | 163,534 |
Revenue Growth | 18.68% | 13.19% | 16.02% | 13.77% | 25.59% | 14.07% |
Gross Profit Gross Profit Growth | 230,230 | 200,302 | 167,896 | 140,571 | 126,279 | 101,018 |
Operating Income Operating Income Growth | 23,636 | 9,798 | 6,678 | 5,061 | 9,381 | -1,084 |
Net Income Net Income Growth | 21,653 | 7,481 | 16,845 | 1,290 | 6,875 | 3,939 |
Earnings Per Share EPS Growth | 1905.01 | 658.00 | 1482.00 | 113.51 | 604.00 | 343.93 |
EPS Growth | 254.74% | -55.60% | 1205.57% | -81.21% | 75.62% | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
South Korea South Korea Growth | 342,097 | 303,500 | 266,189 | 227,826 | 198,952 | 157,998 |
Overseas Overseas Growth | 2,981 | 3,374 | 4,927 | 5,849 | 6,436 | 5,536 |
Total Total Growth | 345,078 | 306,874 | 271,116 | 233,676 | 205,389 | 163,534 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 64,960 | 54,050 | 29,738 | 35,446 | 38,442 | 47,460 |
Total Debt Total Debt Growth | 78,065 | 73,075 | 77,724 | 17,679 | 20,005 | 20,191 |
Net Cash (Debt) Net Cash Growth | -13,105 | -19,024 | -47,986 | 17,767 | 18,437 | 27,269 |
Net Cash Growth | - | - | - | -3.63% | -32.39% | -7.45% |
Net Cash Per Share Net Cash Per Share Growth | -1153.04 | -1673.90 | -4222.08 | 1563.26 | 1620.25 | 2380.83 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 39,371 | 45,683 | 4,914 | -1,328 | 1,788 | 1,472 |
Capital Expenditures CapEx Growth | -10,271 | -8,465 | -75,887 | -5,474 | -2,931 | -4,035 |
Free Cash Flow Free Cash Flow Growth | 29,100 | 37,218 | -70,972 | -6,802 | -1,143 | -2,563 |
Free Cash Flow Growth | -2.81% | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 66.72% | 65.27% | 61.93% | 60.16% | 61.48% | 61.77% |
Operating Margin | 6.85% | 3.19% | 2.46% | 2.17% | 4.57% | -0.66% |
Pretax Margin | 7.59% | 2.51% | 7.47% | 1.83% | 3.59% | 2.33% |
Profit Margin | 6.28% | 2.44% | 6.21% | 0.55% | 3.35% | 2.41% |
FCF Margin | 8.43% | 12.13% | -26.18% | -2.91% | -0.56% | -1.57% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 440.000 | - | - | - | - | - |
Dividend Per Share Growth | 43.86% | - | - | - | - | - |
Dividend Yield | 4.76% | - | - | - | - | - |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 4.86 | 12.85 | 4.41 | 82.90 | 15.19 | 31.13 |
Forward PE | - | 71.34 | 71.34 | 71.34 | 71.34 | 71.34 |
P/FCF Ratio | 3.61 | 2.58 | - | - | - | - |
PS Ratio | 0.30 | 0.31 | 0.27 | 0.46 | 0.51 | 0.75 |